v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 5,632 $ 13,468
Investment in equity securities, at fair value   2,623
Accounts receivable, net of nil expected credit loss 4,092 15,345
Inventories 1,598 5,252
Prepaid expenses and other 2,135 2,888
Total current assets 13,457 39,576
Long-term investments 1,716 1,913
Property, plant and equipment, net 6,968 7,868
Intangible assets, net 221 238
Right of use assets 2,548 3,492
Other assets 740 587
Total assets 25,650 53,674
Current liabilities:    
Accounts payable 1,065 2,723
Bank borrowings 1,001  
Accrued and other current liabilities 24,171 15,344
Convertible notes due to a related party 4,243  
Current portion of long term borrowing 19,190 18,385
Total current liabilities 49,670 36,452
Other liabilities 13,262 15,371
Total liabilities 62,932 51,823
Commitments and contingencies (Note 19)
Shareholders' (deficit) equity:    
$0.0001 par value, 500,000,000 shares authorized 20,967,869 shares and 15,904,533 shares issued at December 31, 2025 and 2024, respectively; 20,555,873 shares and 15,492,581 shares outstanding at December 31, 2025 and 2024, respectively 2 2
Treasury shares, at cost: 411,996 shares and 411,952 shares held at December 31, 2025 and 2024 (9,604) (9,604)
Additional paid-in capital 722,238 713,302
Accumulated other comprehensive loss (1,785) (1,774)
Accumulated deficit (748,133) (700,075)
Total shareholders' (deficit) equity (37,282) 1,851
Total liabilities and shareholders' (deficit) equity $ 25,650 $ 53,674